Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Research & Development: 2023-2025

Historic Research & Development for Biofrontera (BFRI) over the last 2 years, with Sep 2025 value amounting to $854,000.

  • Biofrontera's Research & Development rose 27.65% to $854,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 177.16%. This contributed to the annual value of $2.1 million for FY2024, which is 2612.99% up from last year.
  • Latest data reveals that Biofrontera reported Research & Development of $854,000 as of Q3 2025, which was down 1.84% from $870,000 recorded in Q2 2025.
  • Biofrontera's 5-year Research & Development high stood at $1.2 million for Q1 2025, and its period low was $17,000 during Q1 2024.
  • Its 3-year average for Research & Development is $565,222, with a median of $669,000 in 2024.
  • Data for Biofrontera's Research & Development shows a peak YoY skyrocketed of 7,000.00% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Biofrontera's Research & Development stood at $33,000 in 2023, then skyrocketed by 2,272.73% to $783,000 in 2024, then climbed by 27.65% to $854,000 in 2025.
  • Its Research & Development stands at $854,000 for Q3 2025, versus $870,000 for Q2 2025 and $1.2 million for Q1 2025.